| Rekvina Labs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 526075 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE092O01028 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : -1.25 |
Market Cap(₹Cr) : 19.80 |
Face Value(₹) : 5.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.35 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.35 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 0.35 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenditure | 0.47 | 0.23 | 0.04 | 0.04 | 0.02 | 0.07 |
| PBIDT | -0.12 | -0.03 | -0.04 | -0.04 | -0.02 | -0.07 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | -0.12 | -0.03 | -0.04 | -0.04 | -0.02 | -0.07 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -0.12 | -0.03 | -0.04 | -0.04 | -0.02 | -0.07 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.12 | -0.03 | -0.04 | -0.04 | -0.02 | -0.07 |
| EPS (Unit Curr.) | -0.21 | 0.06 | 0.05 | -0.07 | -0.04 | -0.11 |
| EPS (Adj) (Unit Curr.) | -0.21 | 0.06 | 0.05 | -0.07 | -0.04 | -0.11 |
| Calculated EPS (Unit Curr.) | -0.21 | -0.06 | -0.06 | -0.07 | -0.04 | -0.11 |
| Calculated EPS (Adj) (Unit Curr.) | -0.21 | -0.06 | -0.06 | -0.07 | -0.04 | -0.11 |
| Calculated EPS (Ann.) (Unit Curr.) | -0.82 | -0.23 | -0.23 | -0.28 | -0.16 | -0.44 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -0.82 | -0.23 | -0.23 | -0.28 | -0.16 | -0.44 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 | 3.01 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -34.29 | -15.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDTM(%) | -34.29 | -15.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PATM(%) | -34.29 | -15.00 | 0.00 | 0.00 | 0.00 | 0.00 |
